BACKGROUND: Multiple sclerosis (MS) is a chronic inflammatory autoimmune disorder of the central nervous system. AIM: To explore the genetic basis of three nitric oxide synthase (NOS) genes: NOS1, NOS2A and NOS3, with susceptibility to MS. SUBJECTS AND METHODS: A total of 122 MS patients and 118 healthy controls screened for NOS1 (rs2682826, rs41279104), NOS2A (CCTTT)n/(TAAA)n and NOS3 (rs1800783, rs1800779, rs2070744, 27bpVNTR) markers, using TaqMan®SNP Genotyping Assays and fragment analysis were enrolled in this study. QRT-PCR and ELISA were used to analyse the expression of NOS3 mRNA and Nitric Oxide (NO) levels. RESULTS: Two NOS3 markers were associated with susceptibility to MS and early disease development. The NOS3 rs1800779 G-allele (p = 0.04) and GG-genotype (p = 0.02) showed association with susceptibility to MS. Short NOS2 (CCTTT)n (p = 0.03) and short/long repeat (p = 0.04) genotypes also showed associations with MS. These associations were intensified by sub-division of patients into Kuwaiti Arabs and Persians (p < 0.05). The NOS3-27 bp-VNTR a-allele was associated with early MS disease onset ≤26 years (p = 0.04). The NOS3-27 bp-VNTR a/b-genotype resulted in 23% lower NO production and the NOS3-rs1800779 AA-genotype resulted in lower NOS3 expression. Haplotypes obtained from NOS2A and NOS3 showed increased susceptibility to MS. NOS1 showed no significant association with MS. CONCLUSION: This study provides evidence for the association between selected NOS2 and NOS3 markers and MS susceptibility.
BACKGROUND:Multiple sclerosis (MS) is a chronic inflammatory autoimmune disorder of the central nervous system. AIM: To explore the genetic basis of three nitric oxide synthase (NOS) genes: NOS1, NOS2A and NOS3, with susceptibility to MS. SUBJECTS AND METHODS: A total of 122 MS patients and 118 healthy controls screened for NOS1 (rs2682826, rs41279104), NOS2A (CCTTT)n/(TAAA)n and NOS3 (rs1800783, rs1800779, rs2070744, 27bpVNTR) markers, using TaqMan®SNP Genotyping Assays and fragment analysis were enrolled in this study. QRT-PCR and ELISA were used to analyse the expression of NOS3 mRNA and Nitric Oxide (NO) levels. RESULTS: Two NOS3 markers were associated with susceptibility to MS and early disease development. The NOS3rs1800779 G-allele (p = 0.04) and GG-genotype (p = 0.02) showed association with susceptibility to MS. Short NOS2 (CCTTT)n (p = 0.03) and short/long repeat (p = 0.04) genotypes also showed associations with MS. These associations were intensified by sub-division of patients into Kuwaiti Arabs and Persians (p < 0.05). The NOS3-27 bp-VNTR a-allele was associated with early MS disease onset ≤26 years (p = 0.04). The NOS3-27 bp-VNTR a/b-genotype resulted in 23% lower NO production and the NOS3-rs1800779 AA-genotype resulted in lower NOS3 expression. Haplotypes obtained from NOS2A and NOS3 showed increased susceptibility to MS. NOS1 showed no significant association with MS. CONCLUSION: This study provides evidence for the association between selected NOS2 and NOS3 markers and MS susceptibility.
Authors: Regina F Nasyrova; Polina V Moskaleva; Elena E Vaiman; Natalya A Shnayder; Nataliya L Blatt; Albert A Rizvanov Journal: Int J Mol Sci Date: 2020-02-26 Impact factor: 5.923
Authors: Félix Javier Jiménez-Jiménez; Blanca G Agúndez; Javier Gómez-Tabales; Hortensia Alonso-Navarro; Laura Turpín-Fenoll; Jorge Millán-Pascual; Mónica Díez-Fairén; Ignacio Álvarez; Pau Pastor; Marisol Calleja; Rafael García-Ruiz; Santiago Navarro-Muñoz; Marta Recio-Bermejo; José Francisco Plaza-Nieto; Esteban García-Albea; Elena García-Martín; José A G Agúndez Journal: Front Pharmacol Date: 2021-02-25 Impact factor: 5.810
Authors: Jose Enrique Yuste; Ernesto Tarragon; Carmen María Campuzano; Francisco Ros-Bernal Journal: Front Cell Neurosci Date: 2015-08-17 Impact factor: 5.505